Press Releases

Date	Title	PDF Version
Feb 06, 2018	Data Presented at WORLDSymposium™ 2018 Show Survival to 3 Years of Age and Improvements in Liver Function in Infants with Lysosomal Acid Lipase Deficiency Treated with Kanuma® (sebelipase alfa)
Feb 05, 2018	Alexion Appoints Judith A. Reinsdorf, J.D., to its Board of Directors
Jan 31, 2018	Alexion to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Jan 22, 2018	Alexion Appoints Deborah Dunsire, M.D. to Its Board of Directors
Jan 18, 2018	Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018
Jan 02, 2018	Alexion and Elliott Agree to Collaborate on Identifying a New Board Member
Jan 02, 2018	Alexion to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 26, 2017	Soliris® (Eculizumab) Receives Marketing Authorization in Japan for the Treatment of Patients with Generalized Myasthenia Gravis (gMG)
Dec 20, 2017	Alexion to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Dec 11, 2017	Results of Phase 1b/2 Dose Regimen Optimization Studies for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Presented at American Society of Hematology (ASH) Meeting

Search